Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PG2 Injection 500 mg in Acute Stroke Study (Pass) (Pass)

This study has been completed.
Sponsor:
Collaborators:
National Taiwan University Hospital
Shin Kong Wu Ho-Su Memorial Hospital
Tri-Service General Hospital
Changhua Christian Hospital
National Cheng-Kung University Hospital
Kaohsiung Medical University
En Chu Kong Hospital
Kuang Tien General Hospital
Chung Shan Medical University
Taipei Veterans General Hospital, Taiwan
Kaohsiung Veterans General Hospital.
Taipei Medical University Shuang Ho Hospital
Cheng Hsin Rehabilitation Medical Center
Taipei Medical University WanFang Hospital
Information provided by (Responsible Party):
China Medical University Hospital
ClinicalTrials.gov Identifier:
NCT01603667
First received: May 20, 2012
Last updated: November 3, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)